Corpay, Inc. (CPAY) Cash Flow Statement
Corpay, Inc. (CPAY) generated $1.8B of operating cash flow over the twelve months to 2026-06-30, spent $208.9M on capital expenditure and had free cash flow of $1.6B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CPAYCorpay, Inc.Follow CPAY — free
—
Price chart with a free account
- Market cap
- 26.8B
- P/E TTM
- 24.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.28 | 0.14 | 0.38 | 0.61 | 0.75 | 0.71 | 0.68 | 0.90 | 1.16 | 1.47 | 1.20 | 0.75 | 2.10 | 1.94 | 1.50 | 1.85 | |
| Capital expenditure | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | 0.06 | 0.07 | 0.08 | 0.08 | 0.08 | 0.11 | 0.15 | 0.15 | 0.18 | 0.20 | -0.21 | |
| Free cash flow | 0.27 | 0.12 | 0.35 | 0.58 | 0.71 | 0.65 | 0.61 | 0.82 | 1.09 | 1.39 | 1.09 | 0.60 | 1.95 | 1.77 | 1.30 | 1.64 | |
| Share repurchases | 0.00 | 0.20 | — | 0.00 | 0.00 | 0.19 | 0.40 | 0.96 | 0.69 | 0.85 | 1.36 | 1.41 | 0.69 | 1.29 | 0.78 | — | |
| Stock-based compensation | 0.02 | 0.02 | 0.03 | 0.04 | 0.09 | 0.06 | 0.09 | 0.07 | 0.06 | 0.04 | 0.08 | 0.12 | 0.12 | 0.12 | 0.10 | — |
USD billions · SEC XBRL
Corpay, Inc. — questions
- What is Corpay, Inc.'s operating cash flow?
- $1.8B over the twelve months to 2026-06-30.
- How much does Corpay, Inc. spend on capital expenditure?
- $208.9M over the twelve months to 2026-06-30.
- What is Corpay, Inc.'s free cash flow?
- $1.6B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Corpay, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.